Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Buy: 10x Genomics vs. DermTech

TheMotleyFool

0 0

If you are looking to invest in companies that aim to provide disruptive technology to the healthcare sector, there can be plenty of intriguing options. While some of those may lack a solid foundation to build a high-quality business on, 10x Genomics (NASDAQ: TXG) and DermTech (NASDAQ: DMTK) don't suffer from that issue, and each is well worth your consideration.

Both have immense potential, but which stock is a better buy today? Two Motley Fool contributors battle it out to answer this question.

Image Source: Getty Images.

Source Fool.com

Like: 0

TXG

Share